Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13

Kazimierz Groen, Fredrik H Schjesvold, Bronno van der Holt, Mark-David Levin, Maarten R Seefat, Markus Hansson, Maria B L Leys, Josien C Regelink, Anders Waage, Damian Szatkowski, Per Axelsson, Trung Hieu Do, Asta Svirskaite, Ellen van der Spek, Einar Haukas, Dorota Knut-Bojanowska, Paula F Ypma, Cecilie H Blimark, Ulf-Henrik Mellqvist, Niels W C J van de DonkPieter Sonneveld, Anja Klostergaard, Annette J Vangsted, Niels Abildgaard, Sonja Zweegman*

*Corresponding author af dette arbejde
OriginalsprogEngelsk
TidsskriftHemaSphere
Vol/bind7
Udgave nummer9
Sider (fra-til)e940
ISSN2572-9241
DOI
StatusUdgivet - sep. 2023

Citationsformater